Skip to main content
Clinical Trials/KCT0004657
KCT0004657
Completed
未知

Study on the relieving sensory discomfort in the extremities by anpleOne in patients with small vessel disease of the brain coexisting peripheral arterial stenosis

Seoul National University Hospital0 sites40 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of the nervous system
Sponsor
Seoul National University Hospital
Enrollment
40
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • (1\) Adult men and women over 19 years old
  • (2\) At least 5 years of brain imaging on Brain MRI, SVD findings or similar (\* for patients with headache: added at the bottom)
  • (3\) have been diagnosed with PAD
  • One or more of the following conditions are satisfied.
  • 1\) ABI less than 0\.9
  • 2\) Stenosis rate\> 50% (Duplex ultrasound result PSV ratio\> 2\)
  • Or patients with pain in the lower extremities (or limbs) during activity or rest
  • (4\) Patients who have not recently taken blood circulation improvers (ie, patients who have taken more than 4 weeks)
  • (5\) Those who have not had vascular related procedures for limb arteriovenous veins
  • (6\) Those who have not taken drugs that may affect the nerve sensation within the last 4 weeks

Exclusion Criteria

  • (1\) patients with progressive neurological disease
  • (2\) Those who are already receiving the medication
  • (3\) Those who have clinically significant liver or kidney disease:
  • ALT and / or AST and / or bilirubin is at least three times the upper limit of normal;
  • Creatinine\> 2\.0mg / Dl (176\.7µmol / L) or kidney dialysis
  • (Inspection within the last three months)
  • (4\) A person who has undergone surgery or the like that cannot interfere with the absorption of drugs
  • (5\) those with other psychiatric disorders
  • (6\) Patients who took drugs within 4 weeks that could affect blood flow improvers, pain (including headaches), sensory measurements, etc.
  • (7\) alcohol or drug addicts

Outcomes

Primary Outcomes

Not specified

Similar Trials